Gut microbiome signature of Viliuisk encephalomyelitis in Yakuts includes an increase in microbes linked to lean body mass and eating behaviour.

Sergey Malanin, Galina Karganova, Dmitry Alexeev, Fyodor Platonov, Tatiana Sivtseva, Vladimir Osakovskiy, Viktor Volok, Raisa Nikitina, Vsevolod Vladimirtsev, Veronika Kuznetsova, Tatyana Grigoryeva, Maria Vakhitova, Elena Kostryukova, Natalia Klimenko, Vera Odintsova, Lyudmila Akhmadishina, Alexander Tyakht

Journal: Orphanet journal of rare diseases 2021;15(1):327

PMID: 33218345

Abstract

BACKGROUND

Viliuisk encephalomyelitis (VE) is a rare endemic neurodegenerative disease occurring in the Yakut population of Northeastern Siberia. The main clinical features of VE are spasticity, dysarthria, dementia, central paresis and paralysis, and cortical atrophy observed via MRI. Many hypotheses have been proposed regarding its etiology, including infectious agents, genetics, environmental factors, and immunopathology. Each of these hypotheses has been supported to some extent by epidemiological and experimental data. Nevertheless, none of them has been decisively proven. Gut microbiome is one of the factors that might be involved in VE pathogenesis.

RESULTS

Here we performed a pilot survey of the stool microbiomes of Yakut subjects with VE (n = 6) and without VE (n = 11). 16S rRNA sequencing showed that in comparison with the control group, the Yakuts with VE had increased proportions of Methanobrevibacter and Christensenella, which are reported to be linked to body mass index, metabolism, dietary habits and potentially to neurodegenerative disorders. The identified associations suggest that the microbiome may be involved in VE. Overall, the Yakut microbiome was quite specific in comparison with other populations, such as metropolitan Russians and native inhabitants of the Canadian Arctic.

CONCLUSIONS

Describing the gut microbiome of indigenous human populations will help to elucidate the impact of dietary and environmental factors on microbial community structure and identify risks linked to the lifestyles of such groups as well as endemic diseases.

Address: Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology of Russian Academy of Science, Vavilova Str. 34/5, 119334, Moscow, Russian Federation.; Moscow Institute of Physics and Technology, Kerchenskaya Str. 1A, Moscow, Russian Federation, 117303.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology of Russian Academy of Science, Vavilova Str. 34/5, 119334, Moscow, Russian Federation. [email protected].; Atlas Biomed Group - Knomics LLC, Tintagel House, 92 Albert Embankment, Lambeth, London, SE1 7TY, UK. [email protected].; Sechenov First Moscow State Medical University, Trubetskaya Str. 8-2, 119991, Moscow, Russian Federation.; Atlas Biomed Group - Knomics LLC, Tintagel House, 92 Albert Embankment, Lambeth, London, SE1 7TY, UK.; Federal Research and Clinical Centre of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya Str. 1a, 119435, Moscow, Russian Federation.; Institute of Fundamental Medicine and Biology, Kazan Federal University, K. Marx Str. 18, 420012, Kazan, Russian Federation.; Research Center of Medical Institute, M.K. Ammosov North-Eastern Federal University, Belinsky Str. 58, 677027, Yakutsk, Russian Federation.; Chumakov Institute of Poliomyelitis and Viral Encephalitides (FSBSI "Chumakov FSC R&D IBP RAS), prem. 8, k.17, pos. Institut Poliomyelita, poselenie Moskovskiy, 108819, Moscow, Russian Federation.; ITMO University, Kronverkskiy pr. 49, 197101, Saint-Petersburg, Russian Federation.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.